Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,794 | -13,828 | -53,088 | -39,783 | -11,083 |
| Depreciation Amortization | 233 | 111 | 497 | 384 | 264 |
| Accounts payable and accrued liabilities | 209 | 78 | 543 | 674 | 421 |
| Other Working Capital | 2,675 | 1,295 | -3,429 | -2,007 | -2 |
| Other Operating Activity | 6,989 | 2,984 | 23,232 | 19,936 | 724 |
| Operating Cash Flow | $-19,688 | $-9,360 | $-32,245 | $-20,796 | $-9,676 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -633 | -254 | -506 | -235 | -235 |
| Investing Cash Flow | $-633 | $-254 | $-506 | $-235 | $-235 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -4,568 | -4,568 | N/A |
| Common Stock Issued | 49 | N/A | 73,674 | 74,244 | 13 |
| Other Financing Activity | 0 | 0 | 8,040 | 8,040 | 6,154 |
| Financing Cash Flow | $49 | $N/A | $77,146 | $77,716 | $6,167 |
| Beginning Cash Position | 117,453 | 117,453 | 73,058 | 73,058 | 73,058 |
| End Cash Position | 97,181 | 107,839 | 117,453 | 129,743 | 69,314 |
| Net Cash Flow | $-20,272 | $-9,614 | $44,395 | $56,685 | $-3,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,688 | -9,360 | -32,245 | -20,796 | -9,676 |
| Capital Expenditure | -633 | -254 | -506 | -235 | -235 |
| Free Cash Flow | -20,321 | -9,614 | -32,751 | -21,031 | -9,911 |